Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(8%)
Results Posted
22%(2 trials)

Phase Distribution

Ph not_applicable
8
67%
Ph phase_3
1
8%
Ph phase_2
1
8%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A8 (72.7%)

Trials by Status

recruiting18%
unknown217%
completed975%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12